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In Brief
The mechanisms and implications of aberrant modes of neutrophil transendothelial cell migration remain largely unknown. Here, Nourshargh and colleagues demonstrate that local leukotriene B 4 -induced proteolytic cleavage of endothelial JAM-C by neutrophil elastase promotes neutrophil reverse transendothelial cell migration back into the circulation and is decisive in dissemination of systemic inflammation.
INTRODUCTION
Neutrophil infiltration into interstitial tissues is a critical component of the innate immune response and a hallmark of acute inflammatory reactions. Due to the destructive potential of neutrophils, this response is also intimately associated with the pathogenesis of numerous inflammatory conditions such as ischemia-reperfusion (I-R) injury, rheumatoid arthritis, and atherosclerosis (Nathan, 2006; Phillipson and Kubes, 2011; Mó csai, 2013) . Neutrophil migration out of the vasculature is classically described by the leukocyte adhesion cascade that depicts a well characterized sequence of cellular and molecular events within the vascular lumen as orchestrated by numerous stimulatory and adhesive pathways (Ley et al., 2007) . Less is known about the stages beyond the vascular lumen, though there is a growing understanding of the adhesive interactions that mediate neutrophil interactions with components of venular walls (Ley et al., 2007; Nourshargh et al., 2010; Proebstl et al., 2012; Nourshargh and Alon, 2014) and the molecular and cellular regulation of neutrophil motility in the interstitial tissue (Lä mmermann et al., 2013; Weninger et al., 2014) .
The migration of neutrophils through the endothelial cell (EC) barrier can occur via both paracellular and transcellular modes (Nourshargh et al., 2010; Kolaczkowska and Kubes, 2013) though the former is considered to be the most prevalent in the peripheral circulation (Schulte et al., 2011; Woodfin et al., 2011) . This response is known to be mediated by numerous EC junctional molecules including platelet endothelial cell adhesion molecule-1 (PECAM-1), members of the junctional adhesion molecule (JAM) family, ICAM-2, VE-cadherin, and CD99 (Nourshargh et al., 2010; Voisin and Nourshargh, 2013; Vestweber et al., 2014) . In addition to moving from the vascular lumen to the extravascular tissue, there is now unequivocal evidence for the ability of neutrophils to exhibit reverse motility through the endothelium. Specifically, through the application of a high resolution confocal intravital microscopy (IVM) platform to analysis of leukocyte transmigration in the mouse cremaster muscle, we have noted that neutrophils can exhibit migration through EC junctions in an abluminal-to-luminal direction (Woodfin et al., 2011) . This neutrophil rTEM response is most prevalent in tissues subjected to the sterile injury caused by I-R, an inflammatory insult that is associated with reduced expression of JAM-C at EC junctions (Scheiermann et al., 2009; Woodfin et al., 2011) . Furthermore, pharmacological blockade or genetic deletion of EC JAM-C enhances the frequency of neutrophil rTEM through cremasteric venules (Woodfin et al., 2011) and blockade of EC JAM-C has been shown to promote monocyte rTEM through cultured human umbilical vein ECs (HUVECs) (Bradfield et al., 2007) . Together, these results have identified EC junctional JAM-C as a regulator of polarized movement of leukocytes from the vascular lumen toward the sub-EC space. While the phenomenon of neutrophil rTEM has been illustrated using in vitro models of neutrophil TEM ( (legend continued on next page) and subsequently in vivo within zebrafish embryos (Mathias et al., 2006) , our findings within the mouse cremaster muscle provide direct evidence for neutrophil rTEM within a mammalian system, urging a need for better understanding of this unexpected response (Woodfin et al., 2011) .
To acquire a greater insight into the frequency, regulation, and pathophysiological role of neutrophil rTEM here, we sought to identify the inflammatory trigger(s) that promote neutrophil rTEM in response to I-R. Specifically, because reduced expression and/or functionality of EC JAM-C was instrumental in promoting neutrophil rTEM in vivo, we investigated the mechanism through which EC JAM-C was lost at sites of sterile injury. The results identified endogenous leukotriene B 4 (LTB 4 ) as the mediator responsible for I-R-elicited loss of venular JAM-C and showed that exogenous LTB 4 was highly efficacious at lowering the expression of EC JAM-C in vivo. This effect was neutrophildependent, with neutrophil elastase (NE) governing the cleavage of EC JAM-C at sites of intense neutrophil infiltration. Furthermore, local LTB 4 and NE could both promote notable neutrophil rTEM. Although investigations into the pathophysiological relevance of neutrophil rTEM are at a developing stage, our previous findings suggested an association between neutrophil rTEM and distant organ inflammation (Woodfin et al., 2011) . In line with this possibility, here we show that activation of LTB 4 -NE axis can drive a local inflammatory response to become a systemic multi-organ reaction, providing further evidence for an association between occurrence of neutrophil rTEM and development of secondary organ inflammation.
RESULTS
Endogenously Generated LTB 4 Accounts for Reduced Expression of Local EC JAM-C in Response to I-R The mechanism of EC JAM-C reduction was investigated in a murine model of cremaster muscle I-R (30 min ischemia, 2 hr reperfusion), an injury model that is amenable to rapid and high-resolution intravital microscopy (Woodfin et al., 2011) . This sterile injury model is characterized by profound local neutrophil infiltration and is associated with increased frequency of neutrophil rTEM (Figures 1A-1D ; Movie S1) (Woodfin et al., 2011) . Elevated percentages of neutrophil rTEM were also observed in cremaster muscles injected with lipopolysaccharide (LPS) (26.4% of all TEM events, n = 6 mice, p = 0.040), identifying local endotoxemia as another inflammatory reaction in which neutrophil rTEM can occur. Since I-R-induced neutrophil rTEM was closely linked with loss of JAM-C from venular EC junctions (Figures 1A and 1E) , to determine the mediator(s) that caused this effect, dissected control and I-R stimulated tissues were analyzed by protein array and ELISA. This approach identified numerous inflammatory mediators generated locally in response to I-R, including a number of cytokines (e.g., IL-1b, IL-1a, IL-6), chemokines (MIP-2, KC), C5a, and the lipid mediator LTB 4 ( Figure S1A ; Figures 1F and 1G) . To investigate the impact of these mediators on expression of EC JAM-C in vivo, we injected the stimuli locally into mouse ear skin or cremaster muscles and analyzed the tissues by immunofluorescent staining and confocal microscopy. Based on preliminary studies, a number of these stimuli were analyzed in detail. These included the neutrophil chemoattractants C5a, MIP-2, KC, and LTB 4 , mediators that were tested at doses that induced comparable neutrophil infiltration ( Figure 1H ). While intradermal C5a, MIP-2 and KC had no impact on EC JAM-C expression in skin, LTB 4 reduced JAM-C expression on postcapillary venules ( Figures 1H and 1I ). LTB 4 , but not KC, also reduced the expression of EC JAM-C in cremasteric venules ( Figure 1J ). Locally administered LTB 4 had no impact on protein expression or localization of other key EC junctional molecules such as PECAM-1, VE-cadherin, or JAM-A ( Figure 1H ; Figures S1B and S1C). The functional importance of endogenously generated LTB 4 in the cremaster I-R model was confirmed using the LTB 4 BLT1 receptor antagonist LY293111. Animals pre-treated systemically (intravenously, i.v.) with LY293111 showed significant reduction of local neutrophil infiltration (Figure 1K) but were totally protected from loss of EC JAM-C following I-R ( Figure 1L ). Collectively, these results show that in response to mouse cremasteric I-R, reduced expression of EC JAM-C is accounted for by endogenous LTB 4 and that exogenous LTB 4 is efficacious at causing loss of EC JAM-C. Furthermore, in agreement with our model that reduced functionality of EC JAM-C drives neutrophil rTEM, at doses that induced comparable neutrophil infiltration, local LTB 4 but not KC promoted neutrophil rTEM ( Figure 1M ; Movie S2).
(B) Quantification of transmigrated neutrophils (n = 3-6) and (C) frequency of neutrophil rTEM events (77-72 events, n = 3-7 mice) through mouse cremasteric venules of tissues subjected to I-R or sham operated, involving 14 independent experiments. (D) Time-lapse images of a movie (Movie S1) tracking the rTEM response of a GFP-labeled neutrophil (green) through a venule labeled with anti-PECAM-1 mAb (red) following cremaster I-R. On the left are video micrographs of a venular segment imaged from the luminal side that show a neutrophil (arrow head) in the sub-EC space (t = 2 min) that subsequently re-enters the vascular lumen (from 5 min onward) and eventually crawls back into the circulation (13 min). Right side panels show corresponding transverse sections of selected images. (E) Quantification of junctional EC JAM-C expression acquired from images as shown in (A) (n = 3-6). Images are representative of three independent experiments. (F and G) Inflammatory mediators in homogenated sham and I-R stimulated cremasters as measured by protein array (F) or ELISA (G) (n = 3). (H) Confocal images of mouse ear skin injected locally (4 hr, i.d.) with the indicated stimuli and immunostained for MRP14, VE-cadherin, and JAM-C. Images are representative of five independent experiments. (I and J) Quantification of junctional EC JAM-C expression in ears (I, from images as in H) or cremasters (J) of control tissues or tissues injected locally with the indicated stimuli, as analyzed by confocal microscopy (n = 4-6) from five independent experiments. (K and L) Quantification of transmigrated neutrophils (K) and junctional EC JAM-C expression (L), as analyzed by confocal microscopy, in sham operated controls or I-R injured cremasters in mice pretreated with vehicle or LY293111 (n = 3-5) involving three independent experiments. (M) Frequency of neutrophil rTEM events in cremaster muscles injected locally with saline, LTB 4 or KC (n = 73-129 events, 3-9 mice) involving 15 independent experiments. Data indicate mean ± SEM or percentage of total events ± SEM (C and M). *p < 0.05, **p < 0.01 and ***p < 0.001 as compared to controls and # p < 0.05, ## p < 0.01, ### p < 0.001 as indicated by lines. Scale bars represent 20 mm (A and H) and 10 mm (D). See also Figure S1 and Movies S1 and S2.
LTB 4 -Induced Loss of EC JAM-C Is Neutrophil Dependent Loss of EC JAM-C caused by locally administered LTB 4 occurred in a dose-and time-dependent manner (Figures 2A and 2B) . Significant reduction in expression of EC JAM-C at EC junctions was noted as early as 30 mins post local application of LTB 4 ( Figure 2B ). This was sustained for up to 8 hr and returned to normal by 24 hr ( Figure 2B ). Of note, total expression of venular EC JAM-C (i.e., including junctional and cell body expression) was also significantly reduced post administration of LTB 4, but with a slight temporal delay as compared to junctional JAM-C ( Figures 2B and 2C ). These results suggest that EC JAM-C is initially re-localized from junctions to non-junctional regions (e.g., plasma membrane) following LTB 4 stimulation, in agreement with our findings using the mouse cremaster I-R model (Scheiermann et al., 2009) . This response might then be followed by total loss of the protein at later time points. The time-course of LTB 4 -induced loss of venular JAM-C was directly aligned with time-course of LTB 4 -elicited neutrophil attachment to and migration through venular walls (Figures 2D and 2E) . In addition, while JAM-C was expressed in all types of microvessels (capillaries > venules > arteries in ear skin and cremaster muscle; Figure S2 ), in LTB 4 -stimulated tissues, reduced expression of the molecule was selectively noted in post-capillary venules, the primary sites of neutrophil transmigration. Indeed, in tissues stimulated with locally administered LTB 4 , reduced expression of EC JAM-C was a feature of venular segments supporting intense neutrophil transmigration (''hot-spots'') ( Figures 2F and 2G ). Collectively, these results suggested a role for neutrophils in loss of EC JAM-C. Direct evidence for this was obtained through the use of mice depleted of their circulating neutrophils in which LTB 4 -injected tissues (skin) showed normal expression of venular JAM-C ( Figure 2H ), contrary to the reduced amounts noted in LTB 4 -stimulated control mice. These results indicate that loss of EC JAM-C following LTB 4 stimulation is a neutrophil-dependent phenomenon and implied proteolytic cleavage of the protein as a possible mechanism.
Neutrophil Elastase Cleaves EC JAM-C Because LTB 4 is a potent inducer of NE release and/or cell-surface expression (Rainger et al., 1998; Young et al., 2007) , we considered that this serine protease might cleave EC JAM-C in response to LTB 4. Initial in vitro studies using an anti-NE mAb and an NE-fluorescent activatable substrate (NE680FAST) illustrated the potent ability of LTB 4 to rapidly mobilize intracellular stores of NE protein and to increase NE activity, respectively, to the neutrophil cell surface ( Figures 3A-3C ). Such effects were not noted with C5a or KC. Importantly, mobilization of neutrophil intracellular stores of NE protein and intense neutrophil-associated NE activity could also be observed in vivo in LTB 4 -stimulated tissues as compared to tissues stimulated by other inflammatory mediators ( Figures 3D and 3E ). The use of Elane À/À (NE À/À ) mice or the NE inhibitor GW311616A provided conclusive in vivo evidence for the involvement of NE in JAM-C cleavage ( Figure 3F ; Figure S3 ). Furthermore, purified NE cleaved recombinant soluble JAM-C in vitro, as shown by immunoblot ( Figure 3G ). Collectively, these results demonstrate that neutrophil-derived NE is responsible for loss of EC JAM-C as induced following rapid mobilization of the enzyme to the neutrophil cell surface by LTB 4 .
Binding of NE to Mac-1 Supports Cleavage of JAM-C We next sought to investigate the impact of exogenously administered NE on EC JAM-C in vivo. In contrast to the in vitro ability of NE to cleave JAM-C, local injection of NE into cremaster muscles failed to impact the expression of EC JAM-C ( Figure 4A ). This discrepancy was considered to be due to an essential need for neutrophils in vivo, because exogenous NE failed to significantly induce neutrophil transmigration ( Figure 4B ). Specifically, we hypothesized that neutrophils might be required to present NE to JAM-C on ECs in order for NE to cleave this adhesion molecule. To explore this possibility, we co-injected NE with KC, a chemokine that induced significant neutrophil infiltration but at the dose tested had no impact on EC JAM-C expression ( Figures 4A and 4B ). Cremaster muscles co-injected locally with NE and KC showed similar neutrophil infiltration to that noted with KC alone ( Figure 4B ). However, in contrast to tissues injected with KC or NE alone, tissues stimulated with NE+KC exhibited a significant reduction in EC JAM-C expression (Figure 4A) . Because NE has previously been reported to bind to the neutrophil integrin Mac-1 (Cai and Wright, 1996) and Mac-1 is a ligand for JAM-C (Santoso et al., 2002) , we considered that the underlying reason for the efficacy of LTB 4 to induce cleavage of JAM-C might be due to the ability of the lipid to be both an effective activator of Mac-1 and inducer of NE release.
In support of this, mouse neutrophils stimulated with LTB 4 or KC adhered to ICAM-1-coated slides in a Mac-1-dependent manner ( Figure 4C ), demonstrating activation of the integrin by these neutrophil chemoattractants. Under these in vitro conditions, however, at concentrations that caused comparable adhesion to ICAM-1-coated slides, only LTB 4 was capable of eliciting release of NE ( Figure 4D ). The functional implication of this in relation to JAM-C cleavage was investigated in an assay in which the interaction of neutrophils with JAM-C and ICAM-1-coated slides was analyzed by fluorescent microscopy and JAM-C cleavage was quantified through immunofluorescence detection of JAM-C ( Figures 4E-4H) . Stimulation of cells with LTB 4 or KC again induced comparable neutrophil adhesion to the coated slides (as found with ICAM-1-coated slides), but only LTB 4 stimulation significantly increased cleavage of JAM-C as compared to unstimulated control cells ( Figures 4E-4I ). The latter response was NE dependent, as assessed using an NE inhibitor (GW311616A) ( Figure 4I ). This assay was next extended to explore the possibility that direct interaction of Mac-1 with NE is necessary for cleavage of JAM-C. For this purpose, Elane À/À neutrophils were pre-treated with or without anti-Mac-1 mAb followed by LTB 4 stimulation in the presence of exogenous NE ( Figure 4J ). The resulting cell samples were then washed and placed onto JAM-C-and ICAM-1-coated slides, and after 30 min the slides were fixed and stained for JAM-C expression. In this model, LTB 4 -stimulated Elane À/À cells supplemented with exogenous NE led to JAM-C cleavage, and this response was totally inhibited under conditions of Mac-1 blockade ( Figure 4K ). Finally, co-immunoprecipitation experiments showed that Mac-1 from LTB 4 -stimulated (but not control unstimulated) mouse neutrophils binds to both NE and JAM-C ( Figure 4L ). Collectively, these results further illustrated the importance of NE in JAM-C cleavage and demonstrated that NE bound to neutrophil Mac-1 supported this response.
Local LTB 4 -NE Axis Promotes Neutrophil rTEM
Because LTB 4 and NE were identified as key molecular players in inducing loss of EC JAM-C and we have previously shown that reduced expression of EC JAM-C drives neutrophil rTEM (Woodfin et al., 2011), we next explored the role of the LTB 4 -NE axis in induction of neutrophil rTEM. LTB 4 -induced neutrophil rTEM was significantly suppressed in Elane À/À mice and in wild-type (WT) mice pre-treated with an NE inhibitor ( Figure 5A ). In addition, because KC, a mediator that did not impact the expression of EC JAM-C ( Figure 1H -1J), also failed to elicit a notable frequency of neutrophil rTEM ( Figure 1M ), the effect of the chemokine when co-injected with NE into the cremaster muscle (a reaction that caused local loss of EC JAM-C; Figure 4A ) was tested. This reaction led to profound frequency of neutrophil rTEM as compared to responses detected in mice injected with KC alone ( Figure 5B ).
Collectively, the results demonstrate that locally activated LTB 4 -NE axis is highly effective at promoting neutrophil rTEM.
Activation of LTB 4 -NE Axis Drives a Local Inflammatory Response to Become Systemic
We have previously found an association between loss of EC JAM-C expression and/or functionality, neutrophil rTEM, and distant organ (lung) inflammation (Woodfin et al., 2011) . Having identified LTB 4 as an effective stimulus that triggers NE-mediated loss of EC JAM-C and promoted neutrophil rTEM, we investigated a possible causal relationship between this cascade of events and secondary organ inflammation. In addition to stimulating local neutrophil infiltration ( Figure 6A ), LTB 4 injected into the mouse cremaster muscle elicited neutrophil accumulation into lungs ( Figure 6B ) and tissue damage (plasma protein leakage) in multiple organs, e.g., lung, heart, and liver ( Figure 6C ). Time-course studies illustrated that, after injection of LTB 4 into the mouse cremaster muscle, lung injury peaked at 4 hr and returned to normal by 24 hr ( Figure S4A ). A similar transient profile of lung injury was found in other tissues such as the heart (Figure S4B ). Similarly to the cremaster muscle, intradermal injection of LTB 4 into the ear skin promoted lung neutrophil accumulation ( Figure S4C ) and remote organ damage ( Figure S4D ). These effects were attenuated in Elane À/À mice or in WT mice pretreated with the NE inhibitor GW311616A ( Figure 6A ). Of note, Elane À/À mice and WT mice pretreated with GW311616A exhibited normal neutrophil migration into lungs in response to intranasal instillation of LTB 4 (Figure S4E) , indicating that NE blockade does not directly suppress neutrophil infiltration into lungs. Together these results show that LTB 4 , when administered into a primary tissue site, can promote secondary organ damage in an NE-dependent manner. Importantly, we also noted increased remote organ (lung and heart) damage following cremaster I-R injury, a response that was inhibited in Elane À/À mice ( Figure S4F ).
Because NE was found to be essential in regulating LTB 4 -induced local EC JAM-C expression ( Figure 3F ; Figure S3 ), a potential link between local loss of EC JAM-C and secondary organ inflammation was further investigated. For this purpose, we analyzed the effects of locally administered KC, a neutrophil chemoattractant that did not cause loss of EC JAM-C ( Figures  1H-1J ). When applied locally to the cremaster muscle at a dose that elicited significant local neutrophil infiltration ( Figure 4B ), KC did not cause neutrophil recruitment into lungs ( Figure 6E ). In contrast, while the combined injection of KC and NE into the cremaster muscle induced comparable neutrophil infiltration to that observed with KC alone ( Figure 4B ), KC+NE led to significant neutrophil accumulation into lungs, as compared to responses detected in mice treated with KC or NE alone ( Figure 6E ). Because we have previously shown that KC+NE can cause local loss of EC JAM-C and promote neutrophil rTEM ( Figure 4A and 5B), these results provide strong evidence to suggest that local regulation of EC JAM-C is instrumental in promoting distant organ damage. In support of this, we noted that KC, when injected into the cremaster muscle of mice with specific deletion of EC JAM-C (Tekcre;Jam-3 flox/flox ), caused significant lung edema as compared to responses observed in littermate controls ( Figure 6F ). Collectively, through loss-of-function and gain-offunction studies, these results demonstrate that inflammatory reactions that can mediate NE-induced local loss of EC JAM-C can promote development of secondary multi-organ inflammation.
Soluble JAM-C Is Detected in Plasma of Locally Inflamed Mice and in Trauma Patients
As a consequence of local proteolytic cleavage by NE, we speculated that soluble JAM-C (sJAM-C) might be detectable in plasma of mice after tissue stimulation. The low circulating sJAM-C detected in control mice was significantly increased following intradermal injection of LTB 4 ( Figure 7A mice depleted of their circulating neutrophils ( Figure 7A ), illustrating that as found with local loss of venular EC JAM-C, presence of sJAM-C in plasma is both neutrophil-and NE-dependent. Importantly, elevated sJAM-C was also found in plasma samples from trauma patients as compared to control volunteers ( Figure 7B ). Patients who developed acute respiratory distress syndrome (ARDS) exhibited higher amounts (>50%) of plasma sJAM-C on admission than those who maintained normal lung function ( Figure 7B ). Furthermore, there was a significant correlation between on admission plasma content of sJAM-C and the subsequent severity of multi-organ failure (MOF) as assessed by their Sequential Organ Failure Assessment (SOFA) scores at 48 hr after injury ( Figure 7C ). Thus, in conjunction with our previous findings, there is an association between increased amounts of sJAM-C in plasma and distant organ inflammation following local LTB 4 in mice and importantly post tissue injury in humans.
DISCUSSION
Here we investigated the mechanism through which neutrophil rTEM is triggered in vivo. The results identified the lipid neutrophil chemoattractant LTB 4 as a key mediator capable of promoting proteolytic cleavage of EC JAM-C by NE, a response that drives neutrophil rTEM. The activation of this cascade of events was also associated with dissemination of systemic inflammation, suggesting that targeting LTB 4 -NE axis might be an efficacious means of suppressing secondary organ damage following local inflammation or injury. While neutrophils play a key role in mounting an early innate immune response and have also been intimately associated with the development of acute inflammatory disorders, there is now ample evidence for a broader role for neutrophils in inflammation and immunity (Mantovani et al., 2011; Mó csai, 2013; Mayadas et al., 2014) . Most notably, neutrophils are known to interact with components of the adaptive immune response and have been implicated in the pathogenesis of numerous chronic inflammatory conditions (Mantovani et al., 2011; Mó csai, 2013; Mayadas et al., 2014) . Furthermore, the traditional view of neutrophils exhibiting a short half-life (i.e., < several hours) has been challenged (Tak et al., 2013) , and there is evidence for the existence of neutrophil ''subsets'' exhibiting a wide range of phenotypes in different physiological and pathological conditions (Beyrau et al., 2012; Kolaczkowska and Kubes, 2013) . In addition, while conventionally neutrophils have been considered as cells that move in a one-way direction, there is now evidence for the ability of neutrophils to breach ECs in an abluminal-toluminal direction, i.e., exhibit reverse TEM (Buckley et al., 2006; Mathias et al., 2006; Woodfin et al., 2011) , though our understanding of the prevalence, regulation, and implications of this response are at an early stage.
Through the application of confocal IVM to analysis of inflamed mouse cremaster muscles, we recently reported significant frequency of neutrophil rTEM following I-R (Woodfin et al., 2011) . Mechanistically, rTEM was associated with and indeed promoted by reduced expression and/or function of EC JAM-C (Woodfin et al., 2011) . To gain a better understanding of the inflammatory trigger(s) that promote neutrophil rTEM, we sought to identify the mechanism(s) through which EC JAM-C is lost. Analysis of mouse cremaster muscles subjected to I-R detected an array of endogenously generated mediators, in line with the network of mediators identified in other models of I-R (Iadecola and Anrather, 2011; Smith et al., 2012) . Among these, LTB 4 was identified as a mediator that effectively reduced expression of EC JAM-C in vivo, and through the use of a specific BLT1 receptor antagonist, endogenous LTB 4 was found to be totally accountable for loss of EC JAM-C expression in response to I-R. In agreement with investigations of other disease models (Souza et al., 2000; Kim et al., 2006; Chou et al., 2010) , LTB 4 also contributed to local neutrophil infiltration as elicited by I-R. An important cellular source of this LTB 4 is likely to be the neutrophils themselves (Chen et al., 2006; Afonso et al., 2012; Lä mmermann et al., 2013) . The potent ability of locally administered LTB 4 to cause loss of EC JAM-C was associated with the ability of this mediator to induce neutrophil rTEM. These results are directly in line with our previous findings (Woodfin et al., 2011) and the overall hypothesis that loss of EC JAM-C is instrumental in mediating neutrophil rTEM.
The effect of LTB 4 was selective to JAM-C in that it had no impact on expression of other key EC adhesion molecules. We have previously reported that in response to I-R, EC JAM-C is re-distributed from junctions and intracellular cytoplasmic vesicles toward non-junctional plasma membrane (Scheiermann et al., 2009) . Similarly, our present findings suggest an initial redistribution of the molecule away from EC junctions following LTB 4 stimulation, a response that could support adhesion of neutrophils to the endothelium (Scheiermann et al., 2009 ). Reduction of both junctional and total JAM-C expression at later time points suggested that the protein was also cleaved from ECs in this reaction, and multiple lines of evidence indicated that this was a neutrophil-dependent response. This included the following: (1) The response occurred largely in post-capillary venules, the primary site of neutrophil transmigration, (2) the time-course of the response was directly aligned with the time-course of neutrophil adhesion and transmigration, (3) EC JAM-C loss was most notable at sites of intense neutrophil transmigration (''hot-spots''), and finally, (4) LTB 4 -induced loss of EC JAM-C was abolished in neutrophil-depleted mice. In investigating the mechanism through which neutrophils caused reduced expression of EC JAM-C, we focused our attention on the possible role of NE. This serine protease is expressed within neutrophil azurophil granules and exhibits a broad substrate specificity, including numerous cell-surface receptors and adhesion molecules (Pham, 2006) . Because LTB 4 is highly efficacious at inducing NE degranulation from mouse neutrophils in vitro (Young et al., 2007) , we hypothesized that NE might mediate neutrophil-dependent loss of EC JAM-C. In support of this, LTB 4 showed high efficacy in promoting rapid NE release and/ or cell-surface expression and activity (as mobilized from intracellular stores), both in vitro and in vivo, as compared to other neutrophil chemoattractants. Furthermore, we have recently demonstrated that local LTB 4 can rapidly activate neutrophils within the vascular lumen when the neutrophils are in close apposition to the venular wall and junctions (Finsterbusch et al., 2014) . Direct evidence for the role of NE in mediating LTB 4 -induced loss of venular JAM-C was provided with the use of NE-deficient mice or mice pre-treated with an NE inhibitor. Together, our findings identify the potent ability of LTB 4 to induce mobilization of NE to the neutrophil cell surface as a key factor in the ability of this lipid mediator to cause loss of JAM-C at sites of inflammation.
Activation of the neutrophil BLT1 receptor is efficiently linked to signaling pathways that trigger degranulation of azurophil granules containing NE (Rainger et al., 1998) . This could be of physiological benefit when LTB 4 is generated and localized to the interstitial tissue. Here it can support clearance of pathogens or act as a signal-relay molecule for neutrophil chemotaxis or neutrophil swarming to sites of injury, responses that have been linked to NE and LTB 4 , respectively (Belaaouaj et al., 1998; Afonso et al., 2012; Lä mmermann et al., 2013) . In contrast, under pathological conditions, such as that encountered following I-R injury, excessive generation of LTB 4 might activate neutrophils within the vascular lumen, leading to inappropriate and damaging release of NE at the vessel wall. Based on our findings and proposed model, the latter could lead to cleavage of EC JAM-C and development of rTEM. To achieve this effect, we hypothesized that following its release from azurophil granules, neutrophil surface-bound NE is presented to EC JAM-C during TEM. The concept that serine proteases remain cell bound after fusion of granules with the plasma membrane is well recognized and is considered as a means through which the enzymes are protected from endogenous interstitial protease inhibitors (Owen and Campbell, 1999) . What is less clear, however, is the mechanism through which serine proteases bind to the neutrophil cell surface. In this context while charge-dependent mechanisms have been proposed (Campbell and Owen, 2007) , NE has also been shown to interact with neutrophil Mac-1 (Cai and Wright, 1996) . Building on these findings and the fact that Mac-1 has been identified as a ligand for JAM-C (Santoso et al., 2002) , we extended our hypothesis to a potential role for an LTB 4 -NE-Mac-1 axis in cleavage of JAM-C. activation, the efficacy of LTB 4 to induce JAM-C cleavage resides in the capacity of this mediator to induce NE expression to the neutrophil cell surface. Taking advantage of NE deficient neutrophils, evidence was obtained for the ability of NE to bind to activated Mac-1 upon LTB 4 stimulation, an interaction that facilitated JAM-C cleavage. Importantly, rTEM caused by LTB 4 was NE-dependent, and co-injection of exogenous NE with KC (at doses that individually did not cause neutrophil rTEM) induced profound rTEM, demonstrating that the activation of the LTB 4 -NE axis (through loss-of-function or gain-of-function studies) can lead to loss of EC JAM-C and promotion of neutrophil rTEM. Collectively, these findings provide support for the overall hypothesis that NE is presented to EC JAM-C via activated Mac-1, the latter acting as a molecular ''bridge'' between NE and JAM-C. This provides a mechanism through which JAM-C is cleaved in a selective manner, thus promoting neutrophil rTEM.
At present, the functional implication of neutrophils undergoing reverse TEM is unclear. It is potentially possible that this phenomenon might have a physiological role such as dampening down a local inflammatory response (Mathias et al., 2006; Yoo and Huttenlocher, 2011) and/or reflect a role for neutrophils as cellular sentinels or sirens of inflammation. Alternatively, neutrophil rTEM might play a pathological role such as contributing to turning a local acute inflammatory response into a systemic phenomenon (Woodfin et al., 2011) . Although further studies are required, the results of the present study support the latter. Most notably, local I-R injury or local administration of LTB 4 (cremaster muscle or ear skin) caused remote organ damage. Furthermore, all pharmacological or genetic interventions that suppressed or enhanced neutrophil rTEM (e.g., Elane À/À mice and NE+KC), correspondingly regulated second organ inflammation. Because neutrophils that have undergone rTEM have been shown to exhibit a pro-inflammatory state (Buckley et al., 2006; Woodfin et al., 2011) , the present findings support the paradigm that reverse TEM results in re-entry of a small subset of activated neutrophils into the blood circulation that can contribute to turning a local inflammatory response into a systemic phenomenon. The findings further indicated that NE inhibition had no impact on local neutrophil infiltration into the cremaster muscle, suggesting that although NE is not essential in mediating local neutrophil infiltration, excessive and/or inappropriately generated local NE can promote neutrophil rTEM and remote organ damage. As a consequence of EC JAM-C cleavage by NE, increased amounts of circulating sJAM-C were found in mice locally stimulated with LTB 4 . Elevated concentration of sJAM-C was also found in plasma from trauma patients as compared to healthy controls, a parameter that further increased in patients that developed acute respiratory distress syndrome (ARDS) after admission. ARDS is characterized by severe respiratory failure, and patients with ARDS exhibit $40% mortality rate (Rubenfeld et al., 2005; Wheeler and Bernard, 2007) . Pathophysiology of ARDS is characterized by increased lung permeability and neutrophil infiltration and is typically associated with sepsis and multiple organ failure (MOF) (Matthay and Zemans, 2011) . Our findings, together with the reported elevated plasma content of LTB 4 , as well as NE activity, found in trauma patients that progress to ARDS (Donnelly et al., 1995; Auner et al., 2012) , suggest that similar mechanisms (i.e., LTB 4 -dependent NE cleavage of EC JAM-C) could be taking place following trauma. By extension, the results suggest that blocking JAM-C cleavage by inhibition of NE could be a useful preventative strategy in trauma patients at risk of developing ARDS and MOF. Importantly, NE inhibitors are currently in use in Japan in patients with ARDS associated with systemic inflammatory response syndrome (SIRS), as well as for reducing surgeryinduced pulmonary inflammation (Fujii et al., 2010; Aikawa et al., 2011) . Together, the present study provides previously unknown mechanistic insights into how NE inhibitors might prevent secondary ARDS. Furthermore, because increased plasma content of sJAM-C was associated with traumainduced organ failure and also elevated in serum or synovial fluid from rheumatoid arthritis, psoriatic arthritis, osteoarthritis, and systemic sclerosis patients (Rabquer et al., 2010; Manetti et al., 2013) , we propose that sJAM-C might be a useful vascular-derived biomarker for assessing the extent of a systemic inflammatory response.
In summary, we have identified a role for local LTB 4 and NE as regulators of neutrophil rTEM. Furthermore, although at present the precise functional implications of neutrophils undergoing rTEM remain unclear, the results of this study provide further evidence for this phenomenon being associated with dissemination of inflammation. ), and wild-type C57BL/6 mice were used. All animal experiments were conducted in accordance with the UK Home Office legislations.
Patients
Blood from trauma patients (sampled less than 2 hr after injury) or healthy donor controls was collected in buffered sodium citrate.
Induction of Inflammatory Reactions and Pre-treatments
Inflammatory stimuli such as LTB 4 , LPS, CXCL1 (KC), CXCL2 (MIP-2), C5a, or vehicle control were injected in the ears or the cremaster muscles of anesthetized mice. Some mice were pre-treated (24 hr, orally) with the NE inhibitor GW311616A. Cremaster I-R injury (30 min ischemia followed by 2 hr reperfusion) was induced as previously detailed (Scheiermann et al., 2009 ). In some experiments, the LTB 4 receptor antagonist LY293111 was administered i.v. 15 min prior to I-R.
Whole-Mount Tissue Immunofluorescence Staining
Ears or cremaster muscles were immunostained before being mounted on slides and analyzed by confocal microscopy.
Confocal Microscopy
Immunofluorescently stained cells and whole-mounted tissues were imaged by confocal microscopy and analyzed by IMARIS or ImageJ software.
Quantification of Plasma Soluble JAM-C sJAM-C plasma content was analyzed by ELISA.
Cytokine and Chemokine Expression Profile
The profile of different inflammatory mediators in mouse cremasters was analyzed using the Mouse Cytokine Array Panel A Array Kit or ELISA kits.
In Vitro Digestion of JAM-C Purified recombinant murine JAM-C was incubated with purified NE for 1 hr at 37
. Samples were then resolved in a SDS-PAGE gel and visualized by Western blot.
Co-immunoprecipitation
Bone marrow (BM)-derived neutrophils were purified and stimulated with LTB 4 or left unstimulated. Samples were then lysed, incubated overnight with an anti-Mac-1 mAb, and immunoprecipitated. JAM-C and NE protein content was then analyzed by Western blot.
Immunoblot
Samples were resolved on SDS-PAGE gels and electrotransferred onto PVDF membranes. These were then blocked, incubated with primary and HRP-conjugated secondary antibodies, and developed using a Chemoluminescent Substrate.
In Vitro Neutrophil Adhesion Assay 16-well glass chamber slides were coated with recombinant human ICAM-1 and blocked with 10% BSA. BM Neutrophils (5 3 10 4 /well) were added to the chambers and were either left untreated or stimulated with LTB 4 . In some experiments, neutrophils were pre-incubated with an anti-Mac-1 mAb. The number of adherent cells was quantified by phase contrast microscopy.
Imaging of JAM-C Cleavage In Vitro BM neutrophils seeded in 16-well glass chamber slides coated with recombinant ICAM-1 and JAM-C were left untreated or stimulated with LTB 4 , LTB 4 + GW311616A or KC for 30 min. Slides were then fixed, immunostained with antibodies against JAM-C and MRP-14, and analyzed by confocal microscopy.
In Vivo NE Enzymatic Activity Assay NE680FAST was injected i.v. and left to circulate for 15 min before induction of inflammation. At the end of the experiment tissues were collected, immunofluorescently stained, and analyzed by confocal microscopy.
In Vitro NE Enzymatic Activity Assay BM neutrophils were seeded on ICAM-1 and JAM-C coated slides and left untreated or stimulated for 30 min with KC or LTB 4 in the presence of NE680-FAST. Slides were then washed, fixed, immunostained, and analyzed by confocal microscopy.
Confocal Intravital Microscopy of Mouse Cremaster Muscles
Lyz2-EGFP-ki mice were injected (i.s.) with Alexa-555-PECAM-1 to stain EC junctions of the cremaster microvasculature. After cremaster exteriorization, postcapillary venules were selected for in vivo analysis of leukocyte-vessel wall interactions.
Analysis of Lung Neutrophil Infiltration
Following perfusion of pulmonary vasculature, lungs were excised and digested. The resulting cells were stained and the number of neutrophils analyzed by flow cytometry.
Flow Cytometry
Samples were immunostained with fluorescently conjugated antibodies. Following red blood cell lysis, samples were run on a flow cytometer and analyzed using Flowjo software (TreeStar).
Measurement of Tissue Plasma Extravasation
Evans blue solution was injected i.v. and allowed to circulate for 10 min before mice were killed. Following vascular wash-out, tissues were collected and the accumulated Evans blue (tissue albumin) was quantified as a measure of plasma leakage. Figure S1 The clip shows high optical zoom of a neutrophil migrating through a multi-cellular junction viewed from the luminal side. The neutrophil (green) is initially on the luminal side of the endothelial cell, transmigrates into the sub-endothelial cell space and subsequently migrates through the junction back into the lumen in a 'reverse' direction. On the luminal side the leukocyte disengages from the junction and crawls across the luminal surface. The movie has been created using a software (IMARIS™, Bitplane) that recreates the structures being imaged from individual voxels in 3D via a blend projection algorithm whilst maintaining a transparency function. As a result, since the neutrophil rTEM event is being observed from the luminal side, neutrophils in the vascular lumen are seen as being fully green (closest to the (Cambridge, UK). Antibodies against Ly6G (clone 1A8) and CD45 (clone 30-F11) were obtained from Biolegend (London, UK). Rabbit Polyclonal anti-JAM-C was generated as previously described (Lamagna et al., 2005) .
Animals. Lyz2-EGFP-ki mice (Faust et al., 2000) were used with the permission of Dr Thomas ;Lyz2-EGFP-ki) exhibiting NE deletion and GFP-tagged neutrophils. Endothelial cell specific JAM-C deficient mice (Tekcre;JAM-3 flox/flox ) were generated in house as described before (Woodfin et al., 2011) by cre-mediated recombination of JAM-3 flanked by loxP sites (Langer et al., 2011) under the control of the Tek-promoter. Wild type C57BL/6 mice were obtained from Harlan-Olac (Bicester, UK). All animal experiments were conducted in accordance with the United Kingdom Home Office legislations.
Patients. The study was approved by the East London and City Research Ethics Committee.
All adult trauma patients (>15 years) who met the local criteria for trauma team activation were eligible for enrolment into the Activation of Coagulation and Inflammation in Trauma (ACIT) 2 study. ACIT2 is a study prospectively evaluating aspects of coagulation and inflammation in trauma patients. Exclusion criteria were; arrival at hospital more than 2-hours after injury, transfer from another hospital, known severe liver disease, known bleeding diathesis, administration of >2000ml of fluid prior to enrolment or a burn injury covering more than 5% of the total body surface area. Acute respiratory distress syndrome (ARDS) was defined using the Berlin consensus definitions (Force et al., 2012) . Organ failure at 48h was described using the SOFA Score (Vincent et al., 1998) .
Induction of inflammatory reactions and pre-treatments. Mice were anesthetized by intramuscular (i.m.) injection of 1ml/kg of anesthetic mix (40mg ketamine and 2mg xylazine in saline) before the inflammatory stimuli, namely LTB4 (300ng), LPS (300ng), CXCL1 (KC) (500ng), CXCL2 (MIP-2) (500ng), C5a (1µg) or vehicle control, were injected in the ears (30µl, intradermally, 4h) or the cremaster muscles (400µl, intrascrotally, 4h). In some experiments, purified human NE (1mg/kg) with or without KC (500ng) was injected locally for 4h into cremaster muscles and the NE inhibitor GW311616A (2mg/kg) (Macdonald et al., 2001 ) was orally administrated 24h before induction of inflammation. Cremaster I-R injury was induced in anesthetized mice as previously detailed (Scheiermann et al., 2009) . Briefly, the blood flow to the muscle was stopped by placing a clamp at the base of the exteriorized tissue for 30 min to induce ischemia, after which the clamp was removed to allow reperfusion over a 2h period. Control sham operated mice underwent surgical procedures but not tissue I-R. In some animals the LTB4 receptor antagonist LY293111 (10mg/Kg) was administered i.v.
15 minutes prior to induction of I-R.
Whole-mount tissue immunofluorescence staining. Ears or cremaster muscles were dissected and fixed for 10min in ice-cold PFA 4%. Samples were blocked/permeabilized for 2h at room temperature in PBS containing 12.5% FCS, 12.5% NGS and 0.5% Triton X-100, followed by overnight incubation at 4°C with primary antibodies in PBS containing 5% NGS and 5% FCS. For double or triple staining, some antibodies were directly conjugated with Alexa dyes using commercial Alexa-Fluor monoclonal antibody labelling kits. Otherwise, tissues were incubated with appropriate Alexa fluorescently-labelled secondary antibodies for 3h at 4°C in PBS containing 5% NGS and 5% FCS. After washings, tissues were mounted on slides and analyzed by confocal microscopy.
Confocal microscopy.
Immunofluorescently stained whole-mount tissues were imaged using a Zeiss LSM 5 PASCAL confocal laser-scanning microscope (Carl Zeiss) equipped with Argon (excitation wavelength: 488nm) and HeNe (excitation wavelengths: 543 and 633nm) lasers, or a Leica SP5 (Leica) equipped with argon and helium-neon lasers. Multiple Z-stack images at a resolution of 1024 x 1024 were acquired with an oil immersion Plan-Apochromat 63x (1.4 NA) objective or a 20× water-dipping objective (1.0 NA). The protein expression of junctional EC adhesion molecules was quantified in 3D reconstructed images using IMARIS software (Bitplane) as described before (Colom et al., 2012; Woodfin et al., 2011) . Briefly, an isosurface was created using the VE-Cadherin or PECAM-1 labelled channels and the intensity of immunoreactive proteins of interest within these channels was quantified. Total expression of JAM-C was analyzed using Image J software. The samples were also analyzed for quantification of number of transmigrated neutrophils per field of view using the 3D images and IMARIS software.
Quantification of plasma soluble JAM-C content. Mouse blood was obtained by cardiac puncture and collected in heparin. Samples were centrifuged at 6000xg for 3 min and plasma was collected, frozen in liquid N2 and kept at -80C°. Human plasma was prepared post double centrifugation of blood, collected in buffered sodium citrate, at 1760xg for 10 min and supernatants were then frozen and stored at -80C°. sJAM-C content in plasma was measured by ELISA as follows. ELISA plates were coated with mouse or human JAM-B-Fc or Fc control protein in bicarbonate buffer (100mM pH 9.6). Wells were blocked with a solution of PBS containing 0.05% Tween-20 (PBS-T), 3% BSA, 0.2% gelatin (for human only) and 10µg/ml of purified IgG. After washing in PBS-T, plasma samples diluted 1:1 in PBS-T were added to the wells and incubated overnight at 4°C. Wells were then washed twice in PBS-T, once in PB and then incubated with 10µg/ml monoclonal anti-mouse JAM-C (H36) or 5µg/ml affinity purified rabbit polyclonal anti-human JAM-C (714) (Lamagna et al., 2005; Ody et al., 2007) . Immuno blot. Samples were boiled for 10min in loading buffer containing 2% 2-mercaptoethanol and resolved on SDS-PAGE gels. Proteins were electrotransferred onto PVDF membranes followed by 1h blocking in TBS-Tween containing 5% non-fat milk and incubation overnight at 4°C with primary antibodies in 5% BSA TBS-Tween buffer. After incubation with HRP-conjugated secondary antibodies, membranes were developed using the Supersignal West Pico Chemoluminescent Substrate.
In vitro neutrophil adhesion assay. 16-well glass chamber slides were coated with recombinant human ICAM-1 (2.5µg/ml) in coating buffer (150 mM NaCl, 20 mM Tris-HCl, 2 mM MgCl2, pH 9.0) overnight at 4°C. Slides were then washed and blocked with 10% BSA in PBS for 1h at room temperature. BM neutrophils were isolated from WT mice using an antiLy-6G MicroBead Kit. Neutrophils (5x10 4 /well) in RPMI 1640 media, 10% FCS and 25 mM HEPES were either left untreated or stimulated with LTB4 (1-100nM) or KC (1-100nM) for 30 min at room temperature. In some experiments neutrophils were pre-incubated with an antiMac-1 mAb or an isotype control IgG (both at 40 µg/ml) for 20 min at room temperature. Slides were then washed twice in PBS and fixed in 3% PFA + 0.5% glutaraldehyde in PBS for 2 hours on ice. The number of adherent cells per field of view was quantified from images acquired by phase contrast microscopy.
Imaging of JAM-C cleavage in vitro. 16-well glass chamber slides were coated with recombinant ICAM-1 and JAM-C (2.5µg/ml) as above. BM neutrophils (5x10 4 /well) were left untreated or treated with LTB4 (100nM), LTB4+ GW311616A (5µM) or KC (100nM) for 30min. Slides were then fixed as above and immunostained with antibodies against JAM-C and MRP-14. Slides were analyzed by confocal microscopy and the expression of JAM-C at sites of neutrophil adhesion was quantified with IMARIS software by creating an isosurface on the MRP-14 channel and measuring the intensity of JAM-C within this surface. In some experiments, Elane -/-BM neutrophils were pre-incubated with an anti-Mac-1 (40µg/ml) or isotype control mAb prior to being stimulated with LTB4 (30 min) in the presence or absence of purified NE (0.1mg/ml).
Mouse neutrophil depletion protocol. Specific depletion of circulating neutrophils was achieved by a single i.p. injection of 150 µg of Ultra-LEAF™ Purified anti-mouse Ly-6G mAb for 24h. The protocol resulted in >99% depletion of circulating neutrophils as determined by flow cytometry, while the number of monocytes was not affected. Control non-depleted groups were injected with an isotype-matched mAb.
In vivo NE enzymatic activity assay. The NE-fluorescent activatable substrate NE680FAST (Kossodo et al., 2011) was injected i.v. (4.8nmols) into anesthetized mice and left to circulate for 15 min before induction of ear inflammation as detailed above. Tissues were then collected, fixed in 4% PFA as described above and immunofluorescently stained for VE-Cadherin before being analyzed by confocal microscopy. NE activity was quantified by the fluorescence of the peptide NE680FAST, as measured using ImajeJ software.
In vitro NE enzymatic activity assay. The NE-fluorescent activatable substrate NE680FAST was used to assay NE activity released from BM neutrophils in vitro. Briefly cells (5x10 4 /well) on ICAM-1 and JAM-C coated slides were left untreated or stimulated for 30min with KC (100nM) or LTB4 (100nM) in the presence of NE680FAST (1µM/well). Slides were then washed, fixed, immunostained for neutrophils using an anti-MRP-14 mAb, and the intensity of NE680FAST on the isosurface of MRP-14 channel was analyzed by confocal microscopy and measured with IMARIS software as detailed above.
Confocal intravital microscopy (IVM) of mouse cremaster muscles. Confocal intravital microscopy analysis of the mouse cremaster muscle was conducted as previously detailed (Woodfin et al., 2011) . Briefly, Lyz2-EGFP-ki mice (exhibiting predominantly EGFP hi neutrophils) were injected (i.s.) with an Alexa 555-conjugated mAb against PECAM-1 (4µg) for 2h to stain EC junctions of the cremaster microvasculature. After cremaster exteriorization, postcapillary venules (20-40µm diameter) of stimulated tissues were selected for in vivo analysis of leukocyte-vessel wall interactions using a Leica SP5 confocal microscope incorporating a 20× water-dipping objective (NA 1.0). Acquisition of 3D confocal images over time yielded high-resolution four-dimensional videos of dynamic events that were analysed with IMARIS 4D modelling software (Bitplane; for more details see below). Neutrophils exhibiting reverse TEM (rTEM) were defined as cells that moved in an abluminal-to-luminal direction within endothelial cell junctions (stained with an anti-PECAM-1 mAb). This included cells that fully or partially breached the endothelium from the vascular lumen before exhibiting reverse motility through EC junctions and re-entering the blood flow. Within this overall definition, neutrophils were observed to fully breach EC junctions and completely enter the sub-endothelial cell space (where on occasion sub-EC motility was observed), before reverse migrating back through the endothelium into the vascular lumen. In some instances, neutrophils exhibited partial migration into EC junctions (~70-80% of the cell body), before reverse migrating towards the vascular lumen and re-entering the blood circulation. In all cases of neutrophil rTEM, the cells ultimately showed reverse motility within EC junctions (abluminalto-luminal), ending up in the vascular lumen after disengagement from EC junctions. In contrast, normal neutrophil TEM was classified as a response in which the cells migrated through EC junctions only in a luminal-to-abluminal direction and with no pause (Woodfin et al., 2011) .
All the movies and images are representative 4D and 3D images, respectively, acquired using a complex algorithmic software (IMARIS™, Bitplane). This software recreates the structures being imaged from individual voxels in 3D by using a blend projection algorithm that enables the mixing of voxel values along the viewing direction whilst maintaining a transparency function. In the movies, rTEM responses are largely being viewed from the luminal side of the vessel, which results in a visual overlap of voxels from the Alexa Fluor 555 (PECAM-1; closer to the viewing point) with that of GFP-neutrophils (further away from the viewing point).
Hence when the neutrophil is in the sub-EC space or at EC junctions, the leukocyte is seen to be green with an overlay of red fluorescence. In contrast, when the neutrophil is in the vascular lumen, the voxels nearest to the viewing direction stem from GFP, resulting in the neutrophils being totally green.
Analysis of lung neutrophil infiltration.
Following stimulation of cremaster muscles, the left carotid artery of anesthetized mice was cannulated, a bolus injection of heparin (50U) administered and the mice fully exsanguinated. After ligation of the carotid artery, the cannula was removed and mice were killed by cervical dislocation. The chest cavity was immediately opened and both the thoracic vena cava and aorta just above the diaphragm were clamped. The pulmonary vasculature was then perfused with 10 ml of warm PBS (containing heparin and EDTA) by direct injection into the right ventricle, and collection via a cannula inserted into the left ventricle. Lungs were then excised and digested for 30min at 37°C in 5 ml PBS containing collagenase and DNAse (500 U each). The digested lungs were passed through 40 µm cell strainers and the collected cell suspension centrifuged at 400xg for 10min at 4°C. Finally, cells
were stained and the number of neutrophils analyzed by flow cytometry as detailed below.
Flow cytometry. The efficiency and specificity of the leukocyte depletion protocol as well as lung neutrophil counts were assessed by flow cytometry. Samples were collected and incubated with anti-mouse CD16-CD32 to block Fc receptor-mediated antibody binding (5µg/ml), before staining with fluorescently conjugated antibodies against the pan leukocyte marker CD45, the monocyte marker CD115 and the neutrophil marker Ly6G. Red blood cells were then lysed with ACK lysis buffer (150mM NH3Cl, 1mM KHCO3 and 1mM EDTA) and immunoreactive molecules of interest were measured on a LSR Fortessa flow cytometer (BD) and analyzed using Flowjo software (TreeStar).
MPO enzymatic activity assay. Mouse ears were stimulated i.d. for 4h with LTB4 or vehicle control. Animals were killed and lungs were excised and homogenized in 1ml of homogenizing buffer (600mM NaCl, 0.5% HTAB, 600mM KH2PO4 and 66mM Na2HPO4) using the Precellys24 beat-beading system (Bertin Technologies, France). Samples were then subjected to two cycles of liquid N2 freezing-thawing and homogenized again followed by centrifugation at 13000xg (10min at 4°C). MPO activity of lung supernatants was measured through the use of Enhanced K-Blue TMB Substrate (Oxford Byosystems) with the increase in absorbance at 650nm being measured every 30s for 15min at 37°C using a spectrophotometer (Spectra MR, Dynex Technologies). The enzyme activity was calculated using a standard curve generated with human MPO and expressed as Units/mg of protein.
Analysis of neutrophils in the bronchoalveolar lavage (BAL).
Mice were intranasally challenged with LTB4 (2µg) or vehicle control. After 24h, animals were anesthetized, the chest cavity was opened and the trachea exposed. A catheter was then inserted into the trachea and used to flush the lungs with 2ml PBS containing 0.5mM EDTA. BAL fluid was collected and the % of neutrophils was analyzed by flow cytometry as described above.
Measurement of tissue plasma extravasation. Following local stimulation of cremaster muscles or ears (intradermal) with CXCL1 (KC) (500ng), LTB4 (300ng) or I-R injury (cremaster) in mice with or without pre-treatment with GW311616A (2mg/kg, 24h, orally) (Macdonald et al., 2001) , Evans blue solution (5µl of a 5% solution per gram of mouse weight,)
was injected i.v. into the mice and allowed to circulate for 10 min before the animals were killed. Following vascular wash-out (with PBS containing 5mM EDTA), tissues were collected and the accumulated Evans blue (tissue albumin) was eluted in 1ml of formamide for 24 h at 55°C. Optical density (OD) readings at 620 nm were normalized to formamide alone and used as a measure of plasma extravasation.
